116
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Quantitative Analysis of Tear Film in Patients on Atypical Antipsychotics

, MBBSORCID Icon, , MBBS, MSORCID Icon, , MBBS, MSORCID Icon, , MBBS, MSORCID Icon & , MBBS, MS
Pages 566-571 | Received 09 Apr 2022, Accepted 17 Jan 2023, Published online: 28 Feb 2023

References

  • Smith JA, Albenz J, Begley C. The epidemiology of dry eye disease: report of the epidemiology subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:93–107.
  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–283. doi:10.1016/j.jtos.2017.05.008.
  • Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017 Jul 1;15(3):539–574. doi:10.1016/j.jtos.2017.05.001.
  • Shah S, Jani H. Prevalence and associated factors of dry eye: our experience in patients above 40 years of age at a tertiary care center. Oman J Ophthalmol. 2015;8:151–156. doi:10.4103/0974-620X.169910.
  • Gupta N, Prasad I, Jain R, D’Souza P. Estimating the prevalence of dry eye among Indian patients attending a tertiary ophthalmology clinic. Ann Trop Med Parasitol. 2010;104:247–255. doi:10.1179/136485910X12647085215859.
  • Lemp MA, Foulks GN. The definition and classification of dry eye disease. Ocul Surf. 2007 Apr;5(2):75–92.
  • Fujita M, Igarashi T, Kurai T, Sakane M, Yoshino S, Takahashi H. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol. 2005;140(5):808–813. doi:10.1016/j.ajo.2005.05.025.
  • Aragona P, Giannaccare G, Mencucci R, et al. Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review. British J Ophthalmol. 2021;105:446–453. doi:10.1136/bjophthalmol-2019-315747.
  • Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the physicians’ health studies. Arch Ophthalmol. 2009F;127(6):763–768. doi:10.1001/archophthalmol.2009.103.
  • Sagar R, Dandonar, Gumraj G, et al. The burden of mental disorders acrossthe states of India: the global burden of disease study 1990–2017. Lancet Psychiatry. 2020;7(2):148–161. doi:10.1016/S2215-0366(19)30475-4.
  • India State-Level Disease Burden Initiative Mental Disorders Collaborators. The burden of mental disorders across the states of India: the global burden of disease study 1990–2017. Lancet Psychiatry. 2020 Feb;7(2):148–161.
  • Patel V, Saxena S. Transforming lives, enhancing communities – innovations in global mental health. N Engl J Med. 2014;370:498–501. doi:10.1056/NEJMp1315214.
  • Sönmez İ, Aykan Ü. Psychotropic drugs and ocular side effects. Turk J Ophthalmol. 2014;44:144–150. doi:10.4274/tjo.67944.
  • Richa S, Yazbek JC. Ocular adverse effects of common psychotropic agents: a review. CNS Drugs. 2010 Jun;24(6):501–526. doi:10.2165/11533180-000000000-00000.
  • Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000 Sep;118(9):1264–1268. doi:10.1001/archopht.118.9.1264.
  • Li J, Tripati RC, Tripati BJ. Drug induced ocular disorder. Drug Saf. 2008;Vol. 31:127–141.
  • Oshika T. Ocular adverse effects of neuropsychiatric agents: incidence and management. Drug Saf. 1995;12(4):256–263. doi:10.2165/00002018-199512040-00005.
  • Minhas S, Shailender AU, Thakur A, Anita PY. Dry eye and antipsychotic drugs. IJMSIR. 2019;4:44–47.
  • Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018 Oct;17(3):341–356. doi:10.1002/wps.20567.
  • Muench J, Hamer AM. Adverse effects of antipsychotic medications. Am Fam Physician. 2010 Mar 1;81(5):617–622.
  • Gurnani B, Kaur K, Kumar MC. Current concepts and future trends in dry eye syndrome – a review of literature. TNOA J Ophthalmic Sci Res. 2021;59:38–51. doi:10.4103/tjosr.tjosr_108_20.
  • Senchyna M, Wax MB. Quantitative assessment of tear production: a review of methods and utility in dry eye drug discovery. J Ocul Biol Dis Infor. 2008;1(1):1–6. doi:10.1007/s12177-008-9006-2.
  • Lee JH, Kee CW. The significance of tear film break-up time in the diagnosis of dry eye syndrome. Korean J Ophthalmol. 1988;2:69–71. doi:10.3341/kjo.1988.2.2.69.
  • Uchino M, Uchino Y, Dogru M, et al. Dry eye disease and work productivity loss in visual display users: the Osaka study. Am J Ophthalmol. 2014;157:294–300. doi:10.1016/j.ajo.2013.10.014.
  • Baudouin C, Aragona P, Van Setten G, et al. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol. 2014;98:1168–1176. doi:10.1136/bjophthalmol-2013-304619.
  • Kallarackal GU, Ansari EA, Amos N, Martin JC, Lane C, Camilleri JP. A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer’s tests (ST) in the diagnosis of dry eyes. Eye. 2002 Sep;16(5):594–600. doi:10.1038/sj.eye.6700177.
  • McCullough BD, Heiser DA. On the accuracy of statistical procedures in Microsoft Excel 2007. Comput Stat Data Anal. 2008;52(10):4570–4578. doi:10.1016/j.csda.2008.03.004.
  • IBM Corp. IBM SPSS Statistics for Windows, Version 27.0. Armonk (NY): IBM Corp; Released 2020.
  • Chatterjee S, Agrawal D, Sanowar G, Kandoi R. Prevalence of symptoms of dry eye disease in an urban Indian population. Indian J Ophthalmol. 2021 May;69(5):1061. doi:10.4103/ijo.IJO_1796_20.
  • Ousler GW 3rd, Abelson MB, Johnston PR, Rodriguez J, Lane K, Smith LM. Blink patterns and lid-contact times in dry-eye and normal subjects. Clin Ophthalmol. 2014 May 5;8:869–874. doi:10.2147/OPTH.S56783.
  • Albietz JM. Prevalence of dry eye subtypes in clinical optometry practice. Optometry Vision Sci. 2000 Jul 1;77(7):357–363. doi:10.1097/00006324-200007000-00010.
  • C Sahai A, Malik P. Dry eye: prevalence and attributable risk factors in a hospital-based population. Indian J Ophthalmol. 2005 Apr 1;53(2):87–91. doi:10.4103/0301-4738.16170.
  • Fraunfelder FT, Sciubba JJ, Mathers WD. The role of medications in causing dry eye. J Ophthalmol. 2012 Jan 1;2012:1–8. doi:10.1155/2012/285851.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.